Aj. Fischman et al., SPECT IMAGING OF DOPAMINE TRANSPORTER SITES IN NORMAL AND MPTP-TREATED RHESUS-MONKEYS, The Journal of nuclear medicine, 38(1), 1997, pp. 144-150
Parkinson's disease is characterized by degeneration of dopamine (DA)
neurons and their terminals. Since these neurons contain dopamine tran
sporters (DAT), radioligands that bind to these sites are promising ra
diopharmaceuticals for diagnosis and therapeutic monitoring of disease
progression. We evaluated [I-123]-2 beta-carbomethoxy-3 beta-(4-fluor
ophenyl)-N-(1 -iodoprop-1-en-3-yl)nortropane ([I-123]IACFT) for SPECT
imaging in an MPTP model of parkinsonism. Methods: Three rhesus monkey
s were imaged before and at 1 and 2 mo after treatment with MPTP. The
SPECT results were correlated with motor behavior and PET imaging with
[C-11]-2 beta-carbomethoxy-3 beta-aryltropane ([C-11] - CFT). Also, b
iodistribution was measured by planar imaging. Results: In normal anim
als, striatal accumulation of radioactivity was-rapid and peaked withi
n 30 min. Striatal accumulation of [I-123]IACFT was nearly completely
displaceable with unlabeled CFT (1 mg/kg) but was not affected by a si
milar dose of the serotonin (5-HT) transport inhibitor, citalopram. Th
e striatal to cerebellar ratio measured at 30 min. after injection of
[I-123]IACFT was significantly higher (p < 0.01) than with [C-11]CFT;
similar to 6: 1 versus similar to 2.5: 1. After MPTP treatment this ra
tio decreased to 1.02:1 with IACFT and 1.23:1 with [C-11]CFT. Blood cl
earance of [I-123]IACFT was rapid with a terminal t(1/2) of similar to
30 min. HPLC of plasma samples demonstrated that the concentration of
intact ligand decreases rapidly, approaching zero by 60 min. Low leve
ls of accumulation were measured in extracranial tissues. Conclusion:
These results demonstrate that [I-123]IACFT is an excellent SPECT liga
nd far dopamine transporter sites that combines the critical character
istics of: (a) high striatal to cerebellar ratios, (b) high selectivit
y for dopamine versus 5-HT transporter sites, (c) convenient preparati
on at high-specific activity and radiochemical purity and (d) a striat
al localization rate that is well matched to the physical t(1/2) of I-
123.